問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Principal Investigator
葉士芃
下載
2019-11-27 - 2022-03-31
Condition/Disease
Acute Myeloid Leukemia / FLT3-mutated Acute Myeloid Leukemia
Test Drug
Gilteritinib (ASP2215)
Participate Sites4Sites
Not yet recruiting3Sites
Recruiting1Sites
2021-12-15 - 2025-08-31
Participate Sites3Sites
Terminated3Sites
2016-02-01 - 2027-05-31
Recruiting3Sites
2022-06-30 - 2024-03-12
Recruiting4Sites
2021-09-01 - 2025-08-31
Terminated4Sites
2021-01-01 - 2024-12-31
Participate Sites2Sites
Terminated2Sites
2021-12-10 - 2028-06-30
Recruiting2Sites
Terminated1Sites
2014-01-01 - 2021-12-31
Participate Sites9Sites
Terminated9Sites
2021-10-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2023-06-01 - 2028-03-31
Participate Sites5Sites
Not yet recruiting4Sites
全部
